MedTrace Logo

Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients

NCT02149784 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2017-04-27

No results posted yet for this study

Summary

There is still no perfect treatment suggestion for patients with asymptomatic colorectal cancer with unresectable metastatic disease. Whether patients can benefit from palliative resection of primary tumor or not is still waiting for answer. The investigators hypothesis that asymptomatic metastatic colorectal cancer patients who respond to chemotherapy will benefit from primary tumor resection.

Conditions

  • Colorectal Cancer Metastatic

Interventions

PROCEDURE

Surgical resection of primary tumor

Surgical resection of primary tumor of mCRC patients who were respond to first line chemotherapy'

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Gong Chen, Prof. · Sun Yat-sen University

  • Zhi-zhong Pan, Prof. · Sun Yat-sen University

  • De-Sen Wan, Prof. · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-07-31
Completion
2019-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149784 on ClinicalTrials.gov